Single-cell mRNA cytometry via sequence-specific nanoparticle clustering and trapping
Researchers at the University of Toronto have developed a new technology for a “liquid biopsy” to identify which patients might not respond to standard therapy for prostate cancer before it is delivered. Prostate cancer is the second most common cancer in men and the fifth leading cause of death from cancer in men worldwide, [...]









